#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3280	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2531	384.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1614	1614	C	465	C	381	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3280	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2531	384.0	0	HET	.	.	.	A37T	.	37	37	A	467	467	A	497	A,T	321,116	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4866	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3963	367.3	0	.	n	.	0	T695C	SNP	695	695	T	1214	1214	C	358	C,A,T	305,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4866	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3963	367.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1856	1856	A	427	A	359	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4866	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3963	367.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2490	2490	C	473	C,T	387,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4866	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3963	367.3	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3116	3116	T	393	T,C	325,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4866	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3963	367.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2564	2564	A	475	A	389	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	528	folP	852	852	100.0	folP.l15.c4.ctg.1	1871	84.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1147	1149	AGC	124;123;123	A;G;C	101;100;99	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1132	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3839	88.4	1	SNP	p	S91F	0	.	.	271	273	TCC	867	869	TCC	104;104;104	T;C;C	88;89;87	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1132	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3839	88.4	1	SNP	p	D95G	0	.	.	283	285	GAC	879	881	GAC	103;100;99	G;A;C	86;88;89	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1132	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3839	88.4	1	SNP	p	D95N	0	.	.	283	285	GAC	879	881	GAC	103;100;99	G;A;C	86;88;89	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	458	mtrR	633	633	99.21	mtrR.l6.c17.ctg.1	1611	85.3	0	.	p	.	0	A39T	NONSYN	115	117	GCC	598	600	ACC	139;139;139	A;C;C	112;112;113	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	458	mtrR	633	633	99.21	mtrR.l6.c17.ctg.1	1611	85.3	0	.	p	.	0	R44H	NONSYN	130	132	CGC	613	615	CAC	138;137;137	C;A;C	115;112;114	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	458	mtrR	633	633	99.21	mtrR.l6.c17.ctg.1	1611	85.3	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	796	798	CAC	135;134;135	C;A;C	115;116;115	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	458	mtrR	633	633	99.21	mtrR.l6.c17.ctg.1	1611	85.3	1	SNP	p	G45D	0	.	.	133	135	GGC	616	618	GGC	137;139;140	G;G;C	115;114;115	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	280	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1224	68.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1172	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3292	106.5	1	SNP	p	D86N	0	.	.	256	258	GAC	767	769	GAC	138;138;138	G;A,T;C	119;114,1;118	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1172	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3292	106.5	1	SNP	p	S87R	0	.	.	259	261	AGT	770	772	AGT	137;137;137	A,C;G;T	112,1;117;118	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1172	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3292	106.5	1	SNP	p	S87W	0	.	.	259	261	AGT	770	772	AGT	137;137;137	A,C;G;T	112,1;117;118	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1172	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3292	106.5	1	SNP	p	S87I	0	.	.	259	261	AGT	770	772	AGT	137;137;137	A,C;G;T	112,1;117;118	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1172	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3292	106.5	1	SNP	p	S88P	0	.	.	262	264	TCC	773	775	TCC	136;135;136	T;C;C	121;116;114	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1020	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3077	99.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1748	1750	GGC	139;139;139	G;G;C	114;112;112	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	868	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2889	89.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1528	1530	GCA	127;127;127	G,T;C;A	101,1;102;107	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	868	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2889	89.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1531	1533	ATC	129;130;129	A;T,G;C	110;104,1;109	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	868	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2889	89.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1543	1545	GTG	126;126;128	G;T;G	109;104;103	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	868	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2889	89.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1543	1545	GTG	126;126;128	G;T;G	109;104;103	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	868	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2889	89.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2047	2049	ACC	106;106;105	A,C;C;C	88,1;92;97	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	868	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2889	89.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2101	2103	GCG	105;105;105	G;C;G	91;83;87	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	868	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2889	89.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2101	2103	GCG	105;105;105	G;C;G	91;83;87	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	868	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2889	89.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2224	2226	GGC	107;107;107	G;G;C	87;85;88	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	868	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2889	89.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2233	2235	GGC	106;105;105	G;G;C	87;86;88	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	868	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2889	89.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2251	2253	CCG	104;104;104	C,G;C;G	82,1;85;85	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1102	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3423	96.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	650	porA	1146	1146	99.83	porA.l6.c17.ctg.1	2284	85.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	754	754	C	108	C	90	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	590	porB1b	1035	1035	95.73	porB1b.l6.c30.ctg.1	1819	95.2	0	.	p	.	0	G50N	NONSYN	148	150	GGC	567	569	AAC	109;109;109	A;A;C	99;96;96	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	590	porB1b	1035	1035	95.73	porB1b.l6.c30.ctg.1	1819	95.2	0	.	p	.	0	F135L	NONSYN	403	405	TTT	822	824	CTT	97;98;95	C;T;T	84;83;83	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	590	porB1b	1035	1035	95.73	porB1b.l6.c30.ctg.1	1819	95.2	0	.	p	.	0	R143G	NONSYN	427	429	AGA	846	848	GGA	94;94;95	G;G;A	84;81;81	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	590	porB1b	1035	1035	95.73	porB1b.l6.c30.ctg.1	1819	95.2	0	.	p	.	0	D171G	NONSYN	511	513	GAT	930	932	GGT	100;100;100	G;G;T	84;86;85	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	590	porB1b	1035	1035	95.73	porB1b.l6.c30.ctg.1	1819	95.2	0	.	p	.	0	G189S	NONSYN	565	567	GGC	984	986	AGC	105;105;105	A;G;C	90;95;95	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	590	porB1b	1035	1035	95.73	porB1b.l6.c30.ctg.1	1819	95.2	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1050	1050	T	99	T	95	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	590	porB1b	1035	1035	95.73	porB1b.l6.c30.ctg.1	1819	95.2	1	SNP	p	G120K	0	.	.	358	360	GGT	777	779	GGT	102;100;100	G;G;T	91;89;86	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	590	porB1b	1035	1035	95.73	porB1b.l6.c30.ctg.1	1819	95.2	1	SNP	p	A121D	0	.	.	361	363	GCC	780	782	GCC	99;99;98	G;C;C	85;89;89	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	590	porB1b	1035	1035	95.73	porB1b.l6.c30.ctg.1	1819	95.2	1	SNP	p	A121N	0	.	.	361	363	GCC	780	782	GCC	99;99;98	G;C;C	85;89;89	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1994	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	5188	115.1	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2158	2160	AAT	93;94;94	A;A;T	86;83;81	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	342	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1305	78.5	1	SNP	p	V57M	1	.	.	169	171	ATG	661	663	ATG	131;131;130	A;T;G	111;109;110	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
